Related Experiment Videos
Contraceptive and hormonal medication decision-making for pregnancy prevention and gynaecological symptoms: a
Elena Proffitt1, Disha Dhar2, Lois Harvey-Pescott3
1EGA Institute for Women's Health, University College London, London, UK e.proffitt@ucl.ac.uk.
Background:
There has been a decline in the number of contraceptive appointments and prescriptions in the UK. Existing evidence explores the impact of access, barriers and awareness on contraception use. However, less is known about the nuance of how individuals make these decisions. This review aimed to synthesise recent UK evidence on those assigned female at birth's attitudes, experiences and decision-making around contraception and hormonal medication for pregnancy prevention and/or gynaecological reasons.
Methods:
Five academic databases and six online sources were systematically searched. Included studies were published in English from 2015 onwards and contained primary data on contraceptive decision-making for pregnancy prevention and/or gynaecological treatment in the UK. Studies were critically appraised for methodological reliability and usefulness in answering the review question. Data were coded deductively, inductively grouped conceptually and mapped onto a conceptual framework.
Results:
Twenty-one studies met the inclusion criteria. There were ten qualitative, seven mixed methods and four quantitative studies with more focusing on pregnancy prevention (n=10) than on gynaecological management (n=5) and six focusing on both. The synthesis of substantive decision drivers from both quantitative and qualitative data demonstrates that decision-making is shaped by how methods felt in relation to the body; effects; seeking and navigating information; pressure and reproductive autonomy; and risk perception and desire. A decision-making conceptual framework was developed demonstrating the impact of contextual factors and the process of decision-making.
Conclusions:
Contraceptive and hormonal medication decision-making is a dynamic process shaped by complex trade-off balances, trial-and-error processes, evolving needs and individual contexts. Individuals often want to involve and trust others by sharing the decision-making process. Healthcare consultations must recognise the complexity of choice and use, and support contraceptive and hormonal medication decision-making across the life course.
Related Concept Videos
01:22Birth Control Methods
01:21Intrauterine Drug Delivery Systems
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:22Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
01:30Preventive Healthcare Services
01:25Antidepressant Drugs: Overview